Navigation Links
Synta in Medical News

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes

... Drop Adventrx Pharmaceuticals, Inc. (Amex: ANX ) Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) Add Dyanvax Technologies (Nasdaq: DVAX ) synta Pharmaceuticals Corp. (Nasdaq: SNTA ) Enabling Technologies Index (HHV) Drop Hillenbrand Industries (NYSE: HB ) Add Eurand N.V. (Nasdaq: EU...

QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Cancer Indexes

...trading on March 10, 2008, ISIS Pharmaceuticals (Nasdaq: ISIS ) will replace Pharmion Corp. (Nasdaq: PHRM ) in the HealthShares(TM) Composite Index. synta Pharmaceuticals Corp. (Nasdaq: SNTA ) will replace Pharmion Corp. (Nasdaq: PHRM ) in the Cancer Index. Pharmion is being acquired by Celgene Corp. (...

New type of drug shows promise in attacking melanoma in an innovative way

...of time patients survived without progression of their cancer. The study, according to Dr Anthony Williams, vice president of clinical research at synta Pharmaceuticals Corp. in Lexington, Massachusetts, USA, included 81 patients with metastatic melanoma. Of those, 28 received treatment with the chemot...
Synta in Medical Technology

Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma

...ped under a global collaboration agreement between synta Pharmaceuticals and GlaxoSmithKline. Ongoing Clinical Trials GlaxoSmithKline and synta Pharmaceuticals are currently studying elesclomol ...t GlaxoSmithKline at http://www.gsk.com . About synta Pharmaceuticals Corp. ...

GlaxoSmithKline Reports Further Progress of Oncology Portfolio

...demark of the GlaxoSmithKline group of companies in the United States. *Elesclomol is being developed under a global collaboration agreement between synta Pharmaceuticals and GSK. Cautionary statement regarding forward-looking statements Under the safe harbor provisions of the U.S. Private Securiti...

Synta Oncology Candidate STA-4783 Clinical Trial Results to Be Presented at the ASCO Annual Meeting

...th stage IV metastatic melanoma. In November 2006, synta received Fast Track designation from the FDA for t...he development of STA-4783 in metastatic melanoma. synta plans to initiate a pivotal Phase 3 clinical trial...t of metastatic melanoma in over 30 years. About synta Pharmaceuticals ...

Synta Pharmaceuticals to Host Conference Call Today

...will be archived on the Company's website. About synta Pharmaceuticals synta Pharmaceuticals Corp. is a biopharmaceutical compa...ncluding cancer and chronic inflammatory diseases. synta has a unique chemical compound library, an integra...

Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival

...STA-4783 Fast Track designation in November, 2006. synta plans to initiate a Phase 3 clinical trial to inve...th stage IV metastatic melanoma. In November 2006, synta received Fast Track designation from the FDA for t...he development of STA-4783 in metastatic melanoma. synta plans to initiate a pivotal Phase 3 clinical trial...
Synta in Biological Technology

Microbia Names John McCarthy to Senior Management Team

...or Vice President and Chief Financial Officer for Xanthus Pharmaceuticals, Senior Vice President Corporate Development and Chief Financial Officer for synta Pharmaceuticals, Executive Vice President, Chief Operating Officer and Chief Financial Officer for Exact Sciences, and President of the Managed Care D...

Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...KT) EXELIXIS INC. (NASDAQ: EXEL ) HUMAN GENOME SCIENCES INC. (NASDAQ: HGSI ) MEDAREX INC (NASDAQ: MEDX ) SEATTLE GENETICS INC (NASDAQ: SGEN ) synta PHARMACEUTICALS CORP (NASDAQ: SNTA ) ZYMOGENETICS INC (NASDAQ: ZGEN ) Add ABRAXIS BIOSCIENCE INC (NASDAQ: ABII ) CHUGAI PHARM CO (Tokyo SE: 4...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)

...HHJ) Drop Adventrx Pharmaceuticals, Inc. (Amex: ANX ) Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) Add Dyanvax Technologies (Nasdaq: DVAX ) synta Pharmaceuticals Corp. (Nasdaq: SNTA ) Enabling Technologies Index (HHV) Drop Hillenbrand Industries (NYSE: HB ) Add Eurand N.V. (Nasdaq: EURX...
Other Tags
(Date:1/22/2015)... 22, 2015 Deer Path of Huntley ... Valentine’s Day Happy Hour from 3 p.m. to 4 p.m. on ... Parkway in Huntley, Illinois, serves adults with physical disabilities between the ... include Valentine's Day treats, games and sweetheart-themed karaoke. , For more ...
(Date:1/22/2015)... 22, 2015 Liberty University has received accreditation ... program from the Council for Accreditation of Counseling & ... Liberty’s Center for Counseling & Family Studies , is ... the university’s new School of Behavioral Sciences. Prior to the ...
(Date:1/22/2015)... The City of West Hollywood hosted a news conference on ... anniversary of the Supreme Court decision Roe v. Wade, which legalized ... the Roe vs. Wade decision and the fight to protect a ... City of West Hollywood Councilmember Abbe Land. “We need to continue ...
(Date:1/22/2015)... January 22, 2015 Gabe’s Chemo Duck Program is ... the first app ever created for kids with cancer. The Chemo ... and devices, is filled with enjoyable games to help children of ... The free app helps to keep kids entertained, educated and at ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 VogueQueen is a ... affordable prices and many designers are thrilled to have it ... business announces its new collection of prom dresses for the ... to drive the strategic vision and he focuses on continuing ...
Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2
(Date:12/17/2014)...  HITLAB SM announced today its completion of a ... to current U.S. Food and Drug Administration (FDA) regulations. ... and smart phone application trials utilizing the highest principles ... is determined to improve global healthcare access, quality, and ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of ...  report to their offering. One major ... With continuous advances in technology, it is important to ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Valencell, a leader ... is seeing a staggering demand from its licensees for ... Company revealed, is not solely coming from fitness and ... well. "A wearable is only as useful ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
Other Contents